Poland· PL-100177215
Elestar HCT
A olmesartan medoxomil, amlodipin und hydrochlorothiazid product containing olmesartanum medoxomilum + amlodipinum + hydrochlorothiazidum, registered in Poland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil, amlodipin und hydrochlorothiazid is registered in 9 of 19 countries.
Countries holding a registration under ATC C09DX03 (olmesartan medoxomil, amlodipin und hydrochlorothiazid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Olmesartan medoxomil, amlodipin und hydrochlorothiazid · ATC C09DX03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Olmesartanum medoxomilum + Amlodipinum + Hydrochlorothiazidum
- Manufacturer
- Menarini International Operations Luxembourg S.A.
- Country
- Poland (PL)
- ATC code
- C09DX03
- ATC class
- Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
- gtin05909990926909
- gtin05909990926930
- gtin05909990926893
- gtin05909990926947
- gtin05909990926954
- gtin05909990926961
- gtin05909990926978
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
36 interactions on record for olmesartan medoxomil, amlodipin und hydrochlorothiazid.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil, amlodipin und hydrochlorothiazid · interactions on record
36 records
36 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Olmesartan medoxomil, amlodipin und hydrochlorothiazid in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe23409e-0672-454c-82ed-2fb4cb55a5ee GET /v1/drugs/fe23409e-0672-454c-82ed-2fb4cb55a5ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "20 mg + 5 mg + 12,5 mg",
"packaging": "05909990926893 ¦ Rp ¦ 71771\n14 tabl.\n05909990926909 ¦ Rp ¦ 71772\n28 tabl.\n05909990926930 ¦ Rp ¦ 71773\n56 tabl.\n05909990926947 ¦ Rp ¦ 71774\n98 tabl.\n05909990926954 ¦ Rp ¦ 71775\n10 tabl.\n05909990926961 ¦ Rp ¦ 71776\n50 tabl.\n05909990926978 ¦ Rp ¦ 71777\n500 tabl.",
"substance": "Olmesartanum medoxomilum 20 mg + Amlodipini besilas 5 mg + Hydrochlorothiazidum 12.5 mg",
"common_name": "Olmesartanum medoxomilum + Amlodipinum + Hydrochlorothiazidum",
"pl_product_id": "100177215",
"pozwolenie_nr": "18947",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about olmesartan medoxomil, amlodipin und hydrochlorothiazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.